Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  205.78
+0.51 (0.25%)
AAPL  272.81
+6.63 (2.49%)
AMD  207.65
+11.05 (5.62%)
BAC  50.54
-0.53 (-1.04%)
GOOG  308.09
-3.60 (-1.15%)
META  635.99
-1.26 (-0.20%)
MSFT  388.79
+4.32 (1.12%)
NVDA  189.69
-1.87 (-0.97%)
ORCL  144.18
+2.87 (2.03%)
TSLA  401.68
+1.85 (0.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.